How I plan to Brexit-proof my stocks and shares ISA

Do you fear Brexit will hit the value of your investments? Here’s how I think you can use it to your advantage.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With hardline Brexiteers sounding more like the Walmington-on-Sea Home Guard every day, it’s hardly surprising if private investors are getting nervous.

If we walk away from the EU with no agreement in place, an economic panic is almost certain — and then where would we be? I’m hoping common sense will prevail, but I’m also thinking of ways to reduce any adverse effects on my investment portfolio.

For me, the key approach is to think internationally, and going for FTSE 100 stocks will pretty much have that sorted anyway as the great majority of our top companies are global in their outlook. But you might want to keep away from domestic-focused stocks like banks and housebuilders.

Contrarian

I’m not shunning them myself as the contrarian in me thinks they’re oversold due to excessively pessimistic sentiment. But my investment in Lloyds Banking Group hasn’t been a roaring success so far, and if sleeping easy at night is key for you, then you might want to avoid those two sectors.

Among the more obvious international contenders are, I think, our top oil and pharmaceuticals companies, and I see BP, Royal Dutch Shell, AstraZeneca and GlaxoSmithKline as being pretty much immune to the vagaries of the UK economy.

Only around 25% of AstraZeneca’s turnover, for example, comes from the UK. GlaxoSmithKline is even better insulated, with a mere 5% or so generated on these shores.

Sterling

Those few bring me to two key considerations, world commodity prices and the value of the pound. Firstly, the harder our Brexit, the worse the impact on the currency is likely to be. But a falling pound should actually see share prices rising, as they reflect worldwide demand and are more closely tied to the US dollar than any other currency.

But more than that, commodities are priced in dollars, with the vast bulk of valuable dirt produced and consumed outside our islands. That means producers of oil, metals and minerals should be seeing the value of their revenues rising in sterling terms — and that should mean bigger profits and higher sterling share prices.

On that score, I’m happy with my investment in Sirius Minerals. It’s very much a UK-based company (with its potash assets in Yorkshire), but the sale agreements it has in place are with customers scattered around the globe. Sirius faces risks, but I don’t see Brexit as one of them.

Trusts

If you want more than ‘boring’ FTSE 100 shares, an option is to go for globally-based investment trusts. I love the idea of investment trusts anyway, where shareholders own all of their assets and there’s no conflict of interest between them and customers — because they’re one and the same. And they can provide a nice way to gain exposure to smaller global companies.

Lindsell Train Investment Trust, for example, has consistently been a strong performer, investing in a wide range of assets. Its shares are trading at a sizeable premium to net asset value, mind, so a lot of people probably have the same idea.

Witan Investment Trust and F&C Global Smaller Companies are two more with successful records, giving you options to target larger multinationals or smaller companies respectively. And there are plenty more great investment trusts out there.

Just remember one thing when it comes to Brexit — don’t panic.

Alan Oscroft owns shares of Lloyds Banking Group and Sirius Minerals. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

BP’s share price will keep surging in 2026, according to this broker

BP’s share price is in a strong upward trend right now. And one City brokerage firm seems to believe that…

Read more »

Picture of an easyJet plane taking off.
Investing Articles

These 4 red flags mean I’m avoiding easyJet shares like the plague!

easyJet shares have slumped by around a quarter during the past month. Does this represent a dip-buying opportunity? Royston Wild…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Warren Buffett bought this FTSE 100 stock 20 years ago. Here’s why it’s still worth considering today

Warren Buffett bought shares in Tesco 20 years ago. And the FTSE 100 firm still has a lot of the…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

How on earth is this FTSE 100 household name trading at 6 times earnings?

A recent downturn has made some FTSE 100 stocks look bizarrely cheap, perhaps none more so than this well-known airline…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

How much do you need in a Stocks and Shares ISA for a £100 monthly passive income?

ISA season has come round again! What kind of total might budding Stocks and Shares ISA investors need for a…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

I’m considering 2 explosive UK penny stocks while they’re still cheap!

Mark Hartley considers the investment case for two London-listed companies with soaring prices. They might not be in the penny…

Read more »

Investing Articles

£7,500 invested in Nvidia stock 18 months ago is now worth…

Nvidia (NASDAQ:NVDA) stock has run out of steam lately despite profits still soaring. Could this be a lucrative buying opportunity…

Read more »

Picture of an easyJet plane taking off.
Investing Articles

Should I buy easyJet shares near 52-week lows on a P/E ratio of 5.6?

easyJet shares have tanked amid the Iran conflict and the associated spike in oil prices. Is there a value investing…

Read more »